NASDAQ:PRPO Precipio Q3 2026 Earnings Date & Estimates $18.10 -1.25 (-6.46%) Closing price 10/30/2026 04:00 PM EasternExtended Trading$17.93 -0.17 (-0.94%) As of 10/30/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Precipio is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 10, 2026TimeAfter Market ClosesConference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Precipio in Q3 2026Precipio is expected to post earnings of -$2.00 per share on revenue of $1.68 million. In the same quarter a year earlier Precipio reported -$0.05 per share on revenue of $6.77 million. Precipio last reported on August 14, 2026, posting -$0.12 per share and beating the -$2.00 consensus estimate.Consensus EstimatesConsensus EPS-$2.00Expected Revenue$1.68 millionPrior-Year EPS-$0.05Prior-Year Revenue$6.77 millionExpected Revenue Growth-75.2%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.12 (Beat by +$1.88)Last Quarter Revenue$7.02 millionPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Precipio Q3 2026 Earnings FAQ When does Precipio report Q3 2026 earnings? Precipio (NASDAQ:PRPO) is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Precipio's Q3 2026 earnings call? Precipio's Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Precipio? Analysts expect Precipio to post earnings of -$2.00 per share for Q3 2026. How much revenue is Precipio expected to report? The consensus revenue estimate for Precipio is $1.68 million for Q3 2026. Precipio Earnings HeadlinesPrecipio Announces Q3 2026 Shareholder Update CallOctober 29 at 5:31 PM | tipranks.comPrecipio Announces Q3-2026 Shareholder Update CallOctober 29 at 3:51 PM | insidermonkey.comThe chip inside every TeslaEvery Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Starlink dish and AI satellite Elon launches. When Nvidia tried to buy the company, Elon reportedly fought the deal. Now his filing for 1,000,000 satellites could expand its revenue stream sharply. Dylan believes the stock could see significant movement starting December 8th.November 1 at 1:00 AM | Behind the Markets (Ad)Contrasting Precipio (NASDAQ:PRPO) & Billiontoone (NASDAQ:BLLN)October 29 at 2:46 AM | americanbankingnews.comPrecipio Announces Q3-2026 Shareholder Update CallOctober 28, 2026 | globenewswire.comPrecipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average - Here's WhyOctober 23, 2026 | americanbankingnews.comSee More Precipio Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Precipio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Precipio and other key companies, straight to your email. Email Address About PrecipioPrecipio (NASDAQ:PRPO) (NASDAQ: PRPO) is a biotechnology and medical diagnostics company focused on improving the diagnosis of cancer and other complex diseases. The company combines specialized pathology expertise with laboratory testing and diagnostic technologies intended to help physicians identify disease accurately and support treatment decisions. Precipio provides clinical laboratory services in areas including hematopathology, cytogenetics and molecular diagnostics. Its work is particularly focused on blood cancers and other hematologic disorders, where accurate classification can be challenging. The company’s services are designed for hospitals, laboratories, physicians and other healthcare providers. In addition to its laboratory operations, Precipio develops diagnostic products for use in hematology and oncology. Its product portfolio has included HemeScreen, a molecular testing platform designed to detect genetic alterations associated with hematologic malignancies, and IV-Cell, a cell-culture product intended to improve the quality of chromosome analysis. Precipio is headquartered in New Haven, Connecticut, and serves healthcare customers through its diagnostic testing and laboratory offerings.View Precipio ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Exxon's Refining Profits Soared—Did Chevron Get the Same Windfall?LyondellBasell's Dividend Looks Safer, But a New Risk Could Change ThatEli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?Silicon Shock: Intel's 25% Valuation ResetMarketBeat Week in Review – 10/26 - 10/30DoorDash's $17 Billion Bet on Instacart Faces a Long Regulatory Road AheadAmazon's Record Margins Couldn't Stop the Sell-Off—Here's Why Upcoming Earnings Marriott International (11/2/2026)Diamondback Energy (11/2/2026)Williams Companies (11/2/2026)Vertex Pharmaceuticals (11/2/2026)Realty Income (11/2/2026)Apple (11/2/2026)Palantir Technologies (11/2/2026)Entergy (11/2/2026)Booking (11/3/2026)Ferrari (11/3/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
